Tag: imlunestrant
38
FDA Approves Inluriyo-Verzenio Combination for ESR1-Mutated Breast Cancer FDA Approves Inluriyo-Verzenio Combination for ESR1-Mutated Breast Cancer
cancer September 23, 2026

FDA Approves Inluriyo-Verzenio Combination for ESR1-Mutated Breast Cancer

The all-oral treatment is approved for certain adults with advanced or metastatic ... more

EnglishEspañol